PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 19 filers reported holding PTC THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $42,577,000 | -7.1% | 39,676,000 | 0.0% | 0.36% | +18.1% |
| Q4 2019 | $45,851,000 | +81.9% | 39,676,000 | +64.1% | 0.31% | +62.6% |
| Q3 2019 | $25,210,000 | -5.6% | 24,176,000 | +0.2% | 0.19% | +9.2% |
| Q2 2019 | $26,705,000 | +8.0% | 24,130,000 | 0.0% | 0.17% | -6.5% |
| Q1 2019 | $24,718,000 | +4.7% | 24,130,000 | 0.0% | 0.19% | +7.5% |
| Q4 2018 | $23,602,000 | +11.8% | 24,130,000 | +31.5% | 0.17% | +38.4% |
| Q3 2018 | $21,114,000 | – | 18,350,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |